Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 21, 2026, titled " Torrent Pharma launches oral and injectable formulations of Semaglutide".
Press Release Mar 21 2026
Earlier from Torrent Pharmaceuticals
- Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit
- Press Release Feb 13 2026
- Press Release Nov 07 2025
- Press Release Jul 28 2025